CVS Health vs GSK
CVS Health (CVS), health care, and GSK (GSK), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
CVS Health is worth $111B on the stock market and GSK $99.1B: CVS Health is valued at 12% more. CVS Health trades at 10.1 times earnings and GSK at 17.2; operating margins in their latest fiscal years were 1.16% and 24.3%. Over the past year CVS Health's share price has moved +13.7% and GSK's +6.42%.
Key facts
- CVS Health market value
- $111B
- GSK market value
- $99.1B
- CVS Health P/E
- 10.1
- GSK P/E
- 17.2
- CVS Health revenue
- $402.1BFY to 2025-12-31
- GSK revenue
- $43.4BFY to 2025-12-31
- Superinvestors holding both
- 6
Market values as of .
| Measure | CVS Health | GSK |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size | ||
| Market cap | $111Bhigher | $99.1Blower |
| Revenue | $402.1Bhigher | $43.4Blower |
| Earnings | $1.8Blower | $7.6Bhigher |
| Employees | 219,000higher | 66,841lower |
| Total assets | $253.5Bhigher | $81.1Blower |
| Valuation | ||
| P/E | 10.1lower | 17.2higher |
| P/S | 0.3lower | 2.3higher |
| P/B | 1.4 | — |
| Dividend yield | 3.00% | — |
| Profitability | ||
| Operating margin | 1.16%lower | 24.3%higher |
| Balance sheet | ||
| Net assets | $75.2Bhigher | $21.7Blower |
| Total liabilities | $178.2Bhigher | $59.9Blower |
| Total debt | $64.6Bhigher | $19.2Blower |
| Cash on hand | $8.5Bhigher | $4.5Blower |
| Price change | ||
| Today | -2.09%lower | -1.90%higher |
| 1 year | +13.7%higher | +6.42%lower |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (6)
- Richard Pzena2.6% / <0.1%
- Dodge & Cox team2.1% / 1.1%
- Charles Brandes (founder)0.9% / 0.5%
- Steve Cohen0.3% / 0.2%
- Primecap team0.1% / 0.8%
- Jeremy Grantham (co-founder)0.1% / 0.4%
CVS Health only (16)
- Larry Robbins10.0%
- Prem Watsa8.8%
- Christopher Davis4.4%
- Samantha McLemore2.8%
- Andreas Halvorsen1.1%
- Mark Boyar0.8%
- John Rogers0.7%
- Brandon Haley0.7%
- Josef Lakonishok0.7%
- Rajiv Jain0.5%
- Jim Simons (1938–2024)0.3%
- Ken Griffin0.3%
- Ray Dalio (founder)0.2%
- Paul Tudor Jones0.2%
- Israel Englander0.2%
- Bill Nygren<0.1%
GSK only (5)
- Thomas Kahn0.9%
- Ken Fisher0.5%
- Tweedy, Browne team0.3%
- Howard Gleicher0.1%
- Murray Stahl<0.1%
Percentages are each holding's share of that investor's reported portfolio (under "Both": CVS Health / GSK). Who owns CVS · Who owns GSK
More on CVS Health
Further comparisons
CVS Health against its closest peers
GSK against its closest peers
Learn
Questions and answers
Which is bigger, CVS Health or GSK?
By market value, CVS Health is the larger: $111B against $99.1B for GSK. By revenue in its latest fiscal year, CVS Health is the larger: $402.1B against $43.4B for GSK.
Which has the higher P/E ratio?
GSK: 17.2, against 10.1 for CVS Health. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.
Which has the higher operating margin?
GSK: 24.3%, against 1.16% for CVS Health. Operating margin is operating income as a share of revenue in the latest fiscal year.
Which has more debt?
CVS Health: $64.6B, against $19.2B for GSK. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.
Which superinvestors own both CVS Health and GSK?
In their latest 13F filings, Richard Pzena, Dodge & Cox team, Charles Brandes (founder), Steve Cohen, Primecap team and Jeremy Grantham (co-founder) hold both.
Cite this page
Funkfolio, “CVS Health vs GSK”, data as of 17 November 2026. https://funkfolio.com/compare/cvs-vs-gsk
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.